We demonstrated that MDR2 is constitutively expressed in MTC cells, before any drug treatment, at higher pTNM stages (T4), while no expression is observed in lower pTNM stages (T2 and T3) (Ruggeri et al. 2006). Here, ABCB4 is linked to medullary thyroid gland carcinoma.